A b s t r a c t
Introduction
Ischemic stroke constitutes one of the most urgent public health challenges that are threatening the world in the 21 st century. Ischemic stroke is the most prevalent type of stroke, constituting about 80% of all cases of cerebrovascular injury and the leading cause of long-term disability on the global level [10, 92] . According to the reports, there were 15.3 million incidences of stroke in 2002 alone and the number is projected to increase in the future, if rigorous measures are not adopted to tackle the challenges posed by this disorder [86] . One of the biggest challenges of post-stroke therapy is the short window of treatment, which often makes it impossible for the patient to receive competent medical attention in time to minimize devastating and often irreversible brain damage. Ischemic stroke is caused by a blood clot or occluding arteries in the brain which reduces oxygen supply to the critical tissues of the brain. Obstruction of a blood vessel in the brain brings on the rapid cell death in the core of the offended region and actuates damaging mechanisms in the circumferential area; the penumbra. These mechanisms contribute to the generation of factors that initiate cell death. In particular, a complicated series of biochemical cascades take place in the neurons leading to serious damage of the brain tissue [23, 40] .
Oxidative stress is a disturbance in the oxidantantioxidant balance leading to the potential cellular Communicating author:
Dr. Rajanikant G.K., Associate Professor, School of Biotechnology Coordinator, DBT -Bioinformatics Infrastructure Facility, National Institute of Technology Calicut, Calicut -673601, Kerala, India, phone: +91 495 228 5452, fax: +91 495 228 7250, e-mail: rajanikant@nitc.ac.in damage. As the brain consumes about 20% of the body's total oxygen, neuronal cells are more vulnerable than other cells to oxidative damage, although brain constitutes less than 2% of the total body weight [16] . The significance of oxidative damage as a component of many disease processes in the central nervous system (CNS) is being increasingly recognized. One of the major contributors of oxidative stress is free radicals; superoxide anion (O 2 • -), hydroxyl radical (HO•), lipid radicals (ROO -) and reactive nitrogen species (RNS) such as nitric oxide (NO) [87] . ROS can alter gene/protein expression by acting as second messenger molecules that can influence intercellular signalling cascades, ultimately affecting cell phenotype and function. Furthermore, they can directly oxidize cellular components leading to impairment of the cell and contributing to disease progression [57] .
Experimental stroke studies have confirmed that oxidative stress plays an important role in cerebral damage following ischemia. Oxidative stress is the overproduction of reactive oxygen species (ROS) and other free radicals beyond the ability of the biological system to neutralize their adverse effects [58] . Radicals are produced at low levels in the cell via many biochemical processes such as the mitochondrial electron transport chain. ROS perform many vital cellular functions including redox signalling and defence against invading bacteria and other microorganisms. When produced in excess quantities, free radicals can injure cells by attacking vital cellular constituents, such as proteins, fatty acids/lipids and DNA. The lethality of ROS can be further augmented by NO to produce reactive nitrogen species such as peroxynitrite (ONOO -), a molecule that causes oxidation and nitration of tyrosine residues on proteins. The current review attempts to explore the major role of oxidative stress in elevating the fatality of the stroke; precisely we are giving the bird view of the free radical generation, resultant oxidative stress and its role in the pathogenesis of stroke (Fig. 1 ).
Oxidative stress in ischemic stroke
Cerebral ischemia is the shortage of blood and bloodborne factors to areas of tissues in the brain re sulting in cerebral infarction. The main cause of an is chemic Oxidative stress -assassin behind the ischemic stroke stroke is the sudden occlusion of arteries in the brain due to the formation of plaques or clots [55] . Ce rebral thrombosis is the most common type of stroke. Build-up of plaques on arterial walls due to athe rosclerosis leads to the formation of a thrombus in ar teries such as the carotid, resulting in heightened ischemia and cerebral infarction [77] . In some cases, embolization of the thrombus takes place resulting in a wandering clot that can lodge in arteries supplying blood to the brain, ultimately causing an occlusion [93] . Blockage of arteries eventually causes reduction in the perfusion to the brain, setting up an anoxic condition. Consequence of this anoxic state is the decline in the production of high-energy phosphates [97] . Membrane depolarization occurs as an aftermath of severe alteration in the energy homeostasis further triggering eruptive release of excitatory amino acids such as glutamate into the extracellular space [14] . Glutamate induces increased calcium overload in the neurons by acting upon other different receptors. The heightened calcium level is a path for several catastrophes which are crucial for neural cell death [43] .
Heightened intracellular Ca 2+ , Na + and ADP cause mitochondria to produce destructive ROS. As the brain possesses low levels of antioxidants, neurons are relatively vulnerable to oxidative stress than any other cells of the body [21] . During ischemia, nitric oxide synthase (NOS) activity increases by many folds in the neurons. The glutamate effluxing at synapses, activation of NMDA receptors and elevation in the intracellular Ca 2+ level are the main rationalities behind the elevated activity of NOS. In the context of brain ischemia, the activity of NOS is broadly deleterious and their inhibition or inactivation is neuroprotective. In addition, ischemia leads to the generation of superoxide, through the action of NADPH oxide synthases (NOX), xanthine oxidase (XO), cyclo-oxygenase (COX), and leakage from the mitochondrial electron transport chain and other mechanisms [18, 39, 73] . Highly reactive NO and superoxide are themselves deleterious, however they can combine to form a highly toxic anion, peroxynitrite. The peroxynitrite and other ROS destroy the DNA, actuating the poly(ADP-ribose) polymerase-1 (PARP-1), a DNA repair enzyme. PARP-1 catalyzes the conversion of β-ni co tinamide adenine dinucleotide (NAD+) into nicotinamide (NA) and long polymers of poly(ADP-ribose). As a consequence of PARP-1 over-activation, cellular levels of NAD + depletes impairing NAD + dependent processes such as glycolysis and mitochondrial respiration, which leads to ATP starvation, energy failure and consequently neuronal death [4] (Fig. 2) .
Alternatively, non-selective cation channels such as TRPM2 and TRPM7 can be activated to ensure sustained calcium overload and death [21] . As the extra cellular glutamate increases activation of acid sensing ion channels, they lend their part to the destruction of the neuronal ionic environment [1] . Further after reperfusion there is an upsurge in production of superoxide, NO and peroxynitrate. Reperfusion-induced trauma is actuated after the formation of these radicals in the vicinity of blood vessels. Matrix metallo proteases, highly potent proteases get activated as the level of free radical increases, which degrade collagen and laminins in the basal lamina. The degradation of these structural proteins disrupts the integrity of the vascular wall and BBB permeability [81] . Obviously energy-thirsty neurons fail to carry out their complex roles in maintaining posture, movement and sequencing language. Therefore, multimodal therapies that target the oxidative stress can greatly enhance therapeutic efficiency.
It is a well-known fact that cellular adhesion molecules (CAMs) have a significant contribution in the pathophysiology of ischemic stroke [27] . The up-regulation of CAMs is encountered within few hours of stroke and is responsible for the adhesion and migration of the leukocytes [62] . CAMs operate like anchors to the mobile leukocytes, which get adhered to the endothelial cells and then infiltrate into the injured brain. This permits an additional local ROS release by leukocytes and exacerbates ischemic injury [98] . Secondary damage originates as an aftermath of brain oedema, microvascular failure and vasomotor deficits leading to diminished blood perfusion and inflammation [28] . It requires activation of microglia and brain infiltration of peripheral inflammatory cells. These processes are especially detected during reperfusion resulting in an abrupt massive influx of ROS and leukocytes into the injured brain [7] .
Free radical sources in ischemic stroke
The mitochondrial ROS production Mitochondria are central integrators and transducers of apoptotic signals in neurons. During the onset of ischemia, there is a marked drop in oxygen tension and glucose concentration in the brain tissue. This oxygenglucose deprivation (OGD) causes the accumulation of reducing intermediates and leads to an electron leak, which generates ROS [2] . ROS production depends on the metabolic state of mitochondria, for example, free radical production is greater during state IV (low electron flow and ATP synthesis, low ADP levels, high NADH/ NAD + ratio, and low oxygen consumption) respiration than in state III respiration [58] . In the absence of ADP, electrons derived from succinate can reversibly flow to complex 1, generating increased O 2 production, and for this reason, complex 1 is considered as the major physiologically and pathologically relevant ROS-generating site in the mitochondria [48] .
Nitric oxide (NO•) is produced in mitochondria and is an important modulator of ROS production, as the ETC contains several NO• reactive-redox metal centres. At physiological concentrations, NO• modulates mitochondrial oxygen consumption by inhibiting cytochrome c oxidase in a reversible process [11, 19] . A recent report suggested the involvement of p66Shc in mitochondrial ROS production. This protein forms a molecular complex with cytochrome c, subtracting electrons to catalyze the partial reduction of oxygen to form O 2 . P66Shc, partially localized in the inter-mitochondrial membrane space, is a downstream target of p53 and is indispensable for the increase in ROS production, cytochrome c release, dissipation of mitochondrial transmembrane potential and apoptosis [85] . ROS produced in the cell act in a positive feedback, leading to greater ROS production from mitochondria in a process termed ROS-induced ROS release. In mitochondriadependent apop tosis, molecular signalling returns to Xanthine oxidase as source of ROS Mounting evidence indicates that oxidative stress exacerbated during the phase of reperfusion is the main cause of brain injury in ischemia [41] . Ischemia damages the intricate mitochondrial balance, causing ces sation in the oxidative phosphorylation and initiat ing the breakdown in the energetic equilibrium [88] . As a consequence of energy breakdown, levels of adenosine, inosine and hypoxanthine increase. Normally, hypoxanthine is converted by xanthine dehydrogenase to xanthine and uric acid. However, under ischemic conditions, xanthine dehydrogenase can transmute to xanthine oxidase (XO), which uses oxygen as an electron acceptor [66] . XO generates significant amounts of superoxide anions, despite the low oxygen tension during the ischemia [6] . Under hypoxic conditions, XO metabolizes hypoxanthine and xanthine, to yield O 2 -and H 2 O 2 . Several investigations support the contribution of XO to tissue injury in ischemia/reperfusion. Oxypurinol, an inhibitor of XO was reported to block the production of ROS after ischemia [82] . These data confirm that oxidative stress originating from XO contributes to the neuronal injury during ischemia.
NADPH oxidase NADPH oxidase (NOX) is a multi-subunit enzyme complex found in phagocytic leucocytes and vascular tissues. This membrane bound enzyme is suspected to be the key factor behind abnormal flaring up of the ROS level following ischemic reperfusion. Activated NADPH oxidase responds with increased generation of O 2 -, which can react with water to generate hydroxyl radical and peroxynitrite by interacting with NO [56] . Among the five NOX isoforms (NOX 1-5), NOX2 and NOX4 isoforms are highly localized in the hippocampus CA1 and cerebral cortex. Experiments with NOX2 knockout animals and NOX2 inhibitor-treated animals showed a dramatic reduction in the infarct size, demonstrating the major role of NOX2 in oxidative stress-induced neuronal cell death following ischemia [15, 99] . Hence, targeting specifically the vascular NOX4 or NOX2 isoforms might have advantages over non-specific suppression of the NADPH oxidase [68] . In spite of many reports demonstrating the role of NOX, there is limited knowledge about the factors that govern neuronal NOX stimulation.
NO synthases (NOS)
Nitric oxide plays an important role in ROS mediated inflammation. Accumulating evidence indicates that NO can exert both protective and detrimental effects, depending upon the factors such as the chronological points after the onset of ischemic brain injury and isoform of the NOS and cellular source of NO [31, 47] . Neuronal system harbours 3 kinds of NOS, endothelial NOS (eNOS), which maintains the cerebral blood flow, neuronal NOS (nNOS or NOS1) and in ducible NOS (iNOS or NOS2) that can overproduce NO by distinct stimuli in glial cells [69] . Surprisingly, NO release from eNOS soon after brain ischemia is protective, by promoting vasodilation and by inhibiting microvascular aggregation and adhesion. However, after ischemia, NO produced by over-activation of nNOS and, later, NO release by de novo expression of iNOS contributes maximum to the brain damage. Another neurolytic path that involves NO is the production of highly reactive peroxynitrite, which can be regarded as a late neurotoxic event. The initial rise in NO after ischemia/reperfusion is a result of nNOS activation [42] . The mechanism of nNOS is governed by the intracellular calcium level. The nitric oxide production by eNOS is also calciumdependent, causes vasodilation and ameliorates blood flow in the regions of penumbra during ischemia. Hence, NO produced by eNOS is favourable for supporting collateral microcirculation [12] . Another isoform of NOS (iNOS) is one of the factors contributing to brain injury which will be upregulated in the NF-κB-dependent manner. Cytokine up-regulation after stroke is the key stimulus for the iNOS activation. The iNOS ensues in stretched nitric oxide production. Immediately after ischemia, the hypoxic condition flares up the level of iNOS [44] . iNOS has got a high activity several times greater than that of nNOS and hence, it has got a devastating consequence on the endothelium. The inhibition of iNOS shortens the leukocyte attachment to endothelium, and for that reason, it is one of the important targets against endothelial injury.
Oxidative stress-mediated catastrophes Inflammation
The CNS responds to a variety of attacks with complex inflammatory processes. Inflammation takes part in the recovery after stroke and cerebral injury, but, simultaneously it is one of the threats which may worsen the stroke condition [35] . Inflammation during stroke is intermediated by both soluble factors, especially cytokines and also cellular components such as leukocytes and microglia, many of which have pro-inflammatory properties with promoting or destructive consequences [3, 89] . ROS are generated as part of the natural immune response by inflammatory cells. ROS initiates the elevated expression of inflammatory mediators, such as adhesion molecules and cytokines immediately after stroke. These inflammatory factors establish a platform for leukocytes to adhere the vascular endothelial cells, thereby enhancing their accumulation. As a result, infiltration of leucocytes from the circulation into the ischemic regions shoots up within hours after the onset of stroke [5, 100] . Leukocytes are factories of free radicals as they possess a multicomponent superoxide-generating system, NADPH oxidase. Superoxide generation by phagocytic oxidase takes place in phagosomes, whereas ROS by other oxidases are developed in the intracellular medium in smaller quantities [22] . Likewise, leucocytes (neutrophils) possess myeloperoxidase that generates highly reactive hypochloric acid, in the presence of Cl -and hydrogen peroxide. The effects of leukocytes on the pathogenesis of cerebral ischemia include initiation of thrombosis, decreased cerebral perfusion by occlusion and damage to the blood brain barrier (BBB) [76] .
Drastic biochemical changes take place in the brain cells during the inflammatory response. Neurons are the most vulnerable to the ischemic attack among the cells in the brain. The glial cells (microglia and astrocytes) are important modulators of the immune response, which come to the fore after an ischemic attack. In the burst of respiratory activity, the activated microglia release significant amounts of ROS [59] . Free radical scavengers were found to significantly reduce the infarct volume in a stroke model in mice by limiting the microglial activation [91] . Microglial cells are the resident macrophages and serve as scavengers in the event of inflammation. The initial response is protective as the microglia clear foreign matter and debris, but following ischemia the continued response causes extensive cell damage. The microglia release cytotoxic substances following their activation, contributing to the ischemic damage [32, 89] .
COX-2 is another factor responsible for inflammationmediated damage after stroke. Among the brain cells, the COX-2 enzyme is predominantly expressed by dendritic profiles of glutamatergic neurons. Hyper activation and accumulation of COX-2 can be seen in the neurons, glia, vascular cells, and in inflammatory cells invading the brain during cerebral ischemia. Ischemic injury after cerebral artery occlusion can be attenuated by administering inhibitors of COX-2, with a comparatively wide therapeutic window (6 to 24 hours). In addition, ischemic trauma is aggravated in transgenic mice overexpressing COX-2 and is attenuated in COX-2 deficient mice [95] . This evidence demonstrates the involvement of COX-2 in the neuronal degeneration. However, destructive consequences of COX-2 are multifactorial and the mechanisms of the neuronal injury are not yet clear. The possible means of COX-2 lethality might be COX-2-mediated glutamate excitotoxicity initiating Ca 2+ dysregulation, which in turn sets up the ischemic cascade. On the other hand, COX-2 contributes directly to the inflammatory reaction, thus heightening the deleterious effects to the ischemic brain [38] .
Neuronal cell death pathways ROS carry out a two-fold strategy of attack on the ischemic brain. The first mode of attack is the direct assault on proteins, lipids, nucleic acids and other macromolecular constituents of the cell. The second is the involvement of ROS in the cell signalling pathways leading to the apoptotic cell death after the ischemic insult. ROS act as a molecular trigger for ischemic cell death signalling [65, 81] . The p53 signalling pathways are mediated by ROS released from the mitochondria. p53 is an important regulator of apoptosis following ischemic attack in the neurons. It is a transcription factor that controls the gene expression of products like Bax, Bid and p-53 upregulated modulator of apoptosis (PUMA), which act directly on the mitochondria and induce apoptosis [61] . There is a relationship between p53 signalling and oxidative stress via the upregulation of PUMA, a pro-apoptotic target. ROS are inextricably linked with mitochondrial dysfunction under hypoxic conditions. Mitochondrial dysfunction is implicated in both apoptotic and necrotic cell death by the initiation of cell signalling pathways. ROS trigger the release of the water-soluble protein cytochrome c from the mitochondrial membrane indirectly via the translocation of p53 [26] . The PUMA released by p53 interacts with the Bcl-2 family of proteins to release cytochrome c from the mitochondria. SOD knockout mice show increased levels of cytochrome c and extensive DNA damage after undergoing ischemic stroke, thus establishing the role Oxidative stress -assassin behind the ischemic stroke of ROS as critical to apoptotic cell death [30, 46] . Cytochrome c after several interactions activates caspase-9, which in turn initiates the cytochrome c-dependent caspase cascade. Caspases, or Cysteine-aspartic proteases, are associated with unwanted programmed cell death as part of the pathophysiology of several neurodegenerative diseases including ischemic stroke [79] . Caspase 9 activates caspase -3, 2, 6, 8 and 10. Caspases cleave many substrate proteins like poly (ADPribose) polymerase (PARP) and cause extensive damage to DNA [36] .
Endothelial and neuronal cell apoptosis causes extensive neurological damage after ischemic stroke. It has been demonstrated that the apoptosis inhibitor TAT-BH4 protects the ischemic brain from injury by inducing neuroplasticity and preventing apoptosis in neuronal and endothelial cells [25] . Earlier studies have also shown that TAT-BH4 promotes endothelial cell survival by protecting from ROS-induced injury [30] . This highlights the role of ROS in endothelial cell signalling leading to apoptosis. Apoptosis in cells is determined by the delicate balance between pro-apoptotic and antiapoptotic factors. The Bcl-2 family and the caspase family are major players in the activation of the apoptotic signalling pathway. Caspase cascades are energy dependent and occur in the penumbral region which has a residual supply of blood. The release of apoptotic factors are induced by pro-apoptotic proteins like Bid, Bax and Bim [34] . These proteins disrupt mitochondrial membrane potential, triggering the release of cytochrome c through the permeability transition pore [64] (Fig. 2) . Recent studies have discovered that the levels of the hormone adiponectin increase after ischemic stroke. Adiponectin is involved in the pro-apoptotic signalling cascade involving p38 mitogen-activated protein kinase (p38MAPK) and AMP-activated protein kinase (AMPK) [84] .
Excitotoxicity causes damage after ischemic stroke
Oxidative stress, intracellular Ca 2+ imbalance and glutamate excitotoxicity are closely interrelated in a complex series of biochemical cascades that occur after ischemic stroke [17] . Ca 2+ overload have been established as a trigger for ischemic cell death in neurons [63] . The decrease of ATP generation following ischemia contributes to bio-energetic stress, which results in the inhibition of the Na + /K + ATPase and imbalances in Na + and K + levels in the neurons. As a consequence, there is an increase in intracellular Na + coupled with a significant decrease in the levels of K + in the cell. This leads to membrane depolarization or "anoxic depolarisation" of the neurons located in the core region of the ischemic lesion. Critical biochemical changes involved in the progression of the strokeinduced injury take place simultaneously with the onset of anoxic depolarisation. This results in the further deterioration and the expansion of the ischemic lesion [54] .
Mitochondria act as cellular buffers of Ca 2+ in the cell, accumulating the ions when the cytosolic levels exceed the set-point and releasing once the levels have been lowered by the action of membrane Ca 2+ ATP-ases. The set-point is reached when the influx via the Calcium uniporter is balanced by the outflow from the mitochondrial Na + /Ca 2+ exchanger [63] . The heightened levels of cytosolic Ca 2+ puts a strain on the cell, resulting in the accumulation of Ca 2+ above the maximum levels in the mitochondrial matrix [91] . This results in permeability transition, mitochondrial dysfunction, swelling and the release of cell death factors. Mitochondrial dysfunction produces more ROS resulting in a vicious cycle [63, 83] . The accumulation of Ca 2+ also generates more ROS during ischemia, augmenting the existing oxidative stress in the neurons. Investigations using gene knockout animals deficient in manganese superoxide dismutase, reported an increase in the levels of cytochrome c after ischemia/reperfusion, leading to the conclusion that oxidative stress plays an important role in mitochondrial dysfunction [30, 45, 75] .
Ischemia is accompanied by the release of glutamate from synaptic vesicles and subsequent accumulation in the extracellular spaces (Fig. 1) . The levels of extracellular glutamate have been found to increase after the onset of ischemia [52, 53] . Glutamate is an important neurotransmitter in the mammalian CNS, performing vital roles in the development of neurons and synaptic plasticity [24, 60] . There is evidence that the spontaneous release of glutamate from vesicles is mediated by the levels of cytosolic Ca 2+ . Experiments on the inhibition of the N type Ca 2+ channel blocker were found to reduce glutamate levels significantly. The inhibition of the calcium uniporter was found to prevent glutamate excitotoxicity during ischemia. Another mechanism for the release of glutamate from neurons was found to be the reversal of the Na + /glutamate transporter. Free radicals are involved in the release of glutamate from neurons under ischemic conditions. Further, free radicals have been identified as agents that inhibit the uptake of glutamate by Na + /glutamate trans-porters resulting in excitotoxicity [50, 54, 94] . Antioxidant enzymes like SOD were found to block the accumulation of extracellular glutamate in cells under hypoxia.
Glutamate plays a central role in excitotoxic injury after stroke. Glutamate activates receptors linked to Ca 2+ influx and affects mitochondrial function signi-ficantly. The influx of Ca 2+ by the activation of glutamate mediated receptors triggers the uptake of Calcium by the mitochondria. The increase in the levels of Ca 2+ in the mitochondrial matrix results in the events of membrane permeabilization and mitochondrial dysfunction discussed above [60] . Glutamate excitotoxicity results in a condition called extended neuronal depolarisation (END) [74] . The influx of Ca 2+ has been identified as the cause of END through the activation of an injury induced calcium-permeable channel [51] . Experiments have led to the conclusion that glutamate neurotoxicity has two components: one dependent on the levels of Na and K ions and the other linked to the levels of extracellular Ca 2+ . Glutamate leads to the disruption of Na + levels and results in membrane depolarization and the secondary influx of water and Cl -. This is followed by the acute neuronal swelling contributing to excitotoxic injury. The osmotic gradients developed result in the influx of water into the cell, forming an oedema, which increases the intracranial pressure. The other component is the entry of Ca 2+ via the activation of N-methyl D-aspartate glutamate mediated receptors. The complete loss of calcium homeostasis is the point beyond which neuronal damage cannot be reversed [17] .
In vitro studies have shown that ischemia promotes glutamate-mediated free radical generation in hippocampal neurons. This increase in production of ROS coincides with the increase in intracellular calcium and membrane depolarization, reaching peak values at reoxygenation. The fall in ATP levels results in the inability to remove the Ca 2+ accumulated in the cytosol via membrane ATPases. Thus, a direct relation exists between glutamate accumulations, rise in Ca 2+ levels and free radical generation during hypoxia/reoxygenation [67] . In another mechanism of glutamate-induced injury, the high levels of extracellular glutamate interfere with the uptake of cystine through the cystine/glutamate antiporter. The decreased level of cystine in the cell leads to the depletion of intracellular glutathione (GSH). Glutathione acts as an antioxidant and the lack of it leads to severe oxidative damage from the action of ROS. This form of cell death is known as oxidative glutamate toxicity [71] .
Ischemic stroke therapy and the future The pathophysiology of stroke involves an array of complex and interconnected mechanisms, hence provides a range of potential molecular targets for the treatment of stroke. Modern stroke therapy is limit ed by a small therapeutic window which greatly diminishes the usefulness of the treatment. The nuclear factor erythroid 2-related factor 2 and antioxidant-response element (Nrf2-ARE) pathway is presently documented as the major cellular defence mechanism under oxi dative stress. When activated, Nrf2 specifically targets genes bearing an antioxidant response element, which maintain redox homeostasis and influence the inflammatory response (heme oxygenase, 1-ferritin and glutathione peroxidise). A wide range of natural and synthetic small molecules are potent inducers of Nrf2 activity and has been shown to protect the brain against ischemic injury [49] .
The role of oxidative stress and ROS in stroke injury has been firmly cemented by research and is one of the main concerns of stroke studies. The design of ROS scavengers and antioxidants, which can improve the antioxidant defences of the brain, has become the major part of modern stroke research. Randomized clinical studies involving antioxidants like vitamin E did not however provide conclusive results as to the reduction of ischemic stroke in patients [8] . This emphasises that the molecular mechanisms of ROS signalling after stroke are not fully understood. Since mitochondria are a major player in the ischemic cascade, antioxidants targeted at the organelle are being developed to reduce oxidative stress [78] . The use of recognised antioxidants like vitamin E and C as dietary supplements to reduce the risk of stroke is also being investigated [37] . The effects of multiple antioxidant supplementations are also being investigated [70] . Further, numerous studies have demonstrated a protective effect of hyperbaric oxygen (HBO) therapy in experimental ischemic brain injury. Tai et al. [80] have reported that HBO therapy effectively protects against heat-induced hypothalamic ischemia and oxidative damage, thermoregulatory dysfunction, and mortality against heatstroke. A heatstroke patient with multiple organ dysfunctions has also been successfully treated with HBO.
Moderate cerebral hypothermia initiated within 4 hour window after ischemic stroke has been found to reduce neuronal damage after ischemia by obstructing various inflammatory and injury-inducing pathways [20] . The major advantage of hypothermia treatment Oxidative stress -assassin behind the ischemic stroke is the therapeutic window which is suited for clinical applications [72] . Further, the catalytic antioxidants which mimic endogenous antioxidants like superoxide dismutase and catalase can act as potent free radical scavengers and are expected to confer neuroprotection against oxidative stress [33] .
Conclusion
Oxidative stress has been established as the major contributing factor in ischemic injury to the brain. In this article, we have discussed the role of oxidative stress at each stage of the ischemic injury. The biochemical cascades and signalling pathways triggered by oxidative stress have been highlighted keeping in view of the future development in stroke therapy, which is aimed at attenuating the effects of oxidative stress. The ROS induce neuronal damage via various biochemical pathways, offering numerous targets for stroke treatment. The complexity of mechanisms involved in the pathogenesis of stroke pose a great challenge to researchers studying the biochemistry of stroke. The development of novel antioxidant treatments is based on the complete understanding of the role of oxidative stress in stroke injury. Besides, the preference for antioxidant therapies on the oxidative process has to be evaluated carefully, since there are stages in the destructive neurochemical cascade that are regulated by oxidative mechanisms, and their inactivation may produce a reversed effect -potentiation or exacerbation of the processes leading to cell death. Moreover, stroke is a pathologically and etiologically heterogeneous disease and the risk factors may be different for the diverse stroke subtypes.
